Rep. Lisa C. McClain Sells Off Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN)

Representative Lisa C. McClain (R-Michigan) recently sold shares of Smith & Nephew SNATS, Inc. (NYSE:SNN). In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Smith & Nephew SNATS stock on June 17th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Autoliv (NYSE:ALV) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of XPO (NYSE:XPO) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of Lithia Motors (NYSE:LAD) on 7/22/2025.
• Sold $1,001 – $15,000 in shares of Sanofi (NASDAQ:SNY) on 7/22/2025.
• Sold $1,001 – $15,000 in shares of Waters (NYSE:WAT) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of Group 1 Automotive (NYSE:GPI) on 7/22/2025.

Smith & Nephew SNATS Stock Up 1.5%

SNN stock opened at $37.5330 on Friday. Smith & Nephew SNATS, Inc. has a twelve month low of $23.69 and a twelve month high of $37.58. The company has a quick ratio of 1.40, a current ratio of 3.00 and a debt-to-equity ratio of 0.60. The stock has a market cap of $16.44 billion, a P/E ratio of 17.38, a PEG ratio of 1.03 and a beta of 0.68. The business’s 50-day moving average price is $31.96 and its 200-day moving average price is $29.24.

Smith & Nephew SNATS Cuts Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 3rd will be given a dividend of $0.285 per share. This represents a dividend yield of 210.0%. The ex-dividend date of this dividend is Friday, October 3rd. Smith & Nephew SNATS’s payout ratio is presently 41.20%.

Institutional Trading of Smith & Nephew SNATS

Several institutional investors and hedge funds have recently added to or reduced their stakes in SNN. Bank of Montreal Can raised its stake in Smith & Nephew SNATS by 321.6% during the 2nd quarter. Bank of Montreal Can now owns 3,429,829 shares of the medical equipment provider’s stock valued at $105,056,000 after purchasing an additional 2,616,301 shares during the period. J. Goldman & Co LP bought a new stake in Smith & Nephew SNATS in the 4th quarter worth approximately $47,700,000. Armistice Capital LLC increased its stake in Smith & Nephew SNATS by 258.1% in the 1st quarter. Armistice Capital LLC now owns 1,769,000 shares of the medical equipment provider’s stock worth $50,187,000 after acquiring an additional 1,275,000 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Smith & Nephew SNATS by 6,663.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,210,655 shares of the medical equipment provider’s stock worth $37,082,000 after acquiring an additional 1,192,755 shares during the last quarter. Finally, ABC Arbitrage SA increased its stake in Smith & Nephew SNATS by 1,063.4% in the 2nd quarter. ABC Arbitrage SA now owns 898,635 shares of the medical equipment provider’s stock worth $27,525,000 after acquiring an additional 821,393 shares during the last quarter. Institutional investors own 25.64% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on SNN shares. Canaccord Genuity Group lifted their price objective on Smith & Nephew SNATS from $28.00 to $36.00 and gave the company a “hold” rating in a research report on Monday, August 18th. Wall Street Zen cut Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Friday. Six investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $36.00.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.